Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Parkinson Disease”

269 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 269 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Not applicableUnknownNCT05599659
What this trial is testing

The Calgary Movement Disorders Advanced Care Pilot Program

Who this might be right for
Parkinson's Disease and Parkinsonism
University of Calgary 100
Not applicableLooking for participantsNCT07284342
What this trial is testing

Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

Who this might be right for
Advanced Parkinson's Disease
AbbVie 103
Not applicableLooking for participantsNCT06965374
What this trial is testing

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

Who this might be right for
Parkinson Disease
AbbVie 270
Not applicableUnknownNCT02154724
What this trial is testing

Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease

Who this might be right for
Advanced Parkinson's Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Early research (Phase 1)Looking for participantsNCT07161414
What this trial is testing

Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Who this might be right for
Advanced Solid Tumors
AstraZeneca 40
Large-scale testing (Phase 3)Study completedNCT00203164
What this trial is testing

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 254
Early research (Phase 1)Study completedNCT02403193
What this trial is testing

Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Palobiofarma SL 92
Testing effectiveness (Phase 2)Ended earlyNCT04521621
What this trial is testing

Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)

Who this might be right for
Neoplasm Metastasis
Merck Sharp & Dohme LLC 76
Testing effectiveness (Phase 2)Study completedNCT03776136
What this trial is testing

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)

Who this might be right for
Advanced Melanoma
Merck Sharp & Dohme LLC 103
Testing effectiveness (Phase 2)Study completedNCT02271503
What this trial is testing

Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease
Impax Laboratories, LLC 26
Testing effectiveness (Phase 2)Study completedNCT01291537
What this trial is testing

Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Poitiers University Hospital 56
Not applicableLooking for participantsNCT05916157
What this trial is testing

An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
AbbVie 250
Large-scale testing (Phase 3)Study completedNCT00196911
What this trial is testing

STN-Stimulation Versus Best Medical Treatment in Advanced PD

Who this might be right for
Parkinson's Disease
German Parkinson Study Group (GPS) 156
Large-scale testing (Phase 3)UnknownNCT02605434
What this trial is testing

Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients

Who this might be right for
Parkinson's Disease
Intec Pharma Ltd. 420
Testing effectiveness (Phase 2)Looking for participantsNCT05319730
What this trial is testing

Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 230
Large-scale testing (Phase 3)Study completedNCT03040999
What this trial is testing

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

Who this might be right for
Head and Neck Neoplasms
Merck Sharp & Dohme LLC 804
Large-scale testing (Phase 3)UnknownNCT00260793
What this trial is testing

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Agarwal, Pinky, M.D. 20
Testing effectiveness (Phase 2)UnknownNCT05915481
What this trial is testing

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Who this might be right for
Advanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint Inhibitor+2 more
Peking University Third Hospital 60
Large-scale testing (Phase 3)Study completedNCT00244387
What this trial is testing

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Who this might be right for
Parkinson Disease, Idiopathic
UCB Pharma 506
Load More Results